Russell Buchanan

1.6k total citations
54 papers, 887 citations indexed

About

Russell Buchanan is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Russell Buchanan has authored 54 papers receiving a total of 887 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Rheumatology, 16 papers in Pulmonary and Respiratory Medicine and 12 papers in Genetics. Recurrent topics in Russell Buchanan's work include Systemic Lupus Erythematosus Research (16 papers), Vasculitis and related conditions (12 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Russell Buchanan is often cited by papers focused on Systemic Lupus Erythematosus Research (16 papers), Vasculitis and related conditions (12 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Russell Buchanan collaborates with scholars based in Australia, United Kingdom and United States. Russell Buchanan's co-authors include Katerina A. Drouvalakis, David Liew, Claire Owen, R. A. Smallwood, Neville D. Yeomans, Patrick J Venables, G Kraag, Lionel Schachna, Adrienne Morgan and Alberta Hoi and has published in prestigious journals such as Annals of the Rheumatic Diseases, Osteoporosis International and Lara D. Veeken.

In The Last Decade

Russell Buchanan

52 papers receiving 836 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Russell Buchanan Australia 19 432 167 155 151 111 54 887
Arturo Rodríguez de la Serna Spain 15 630 1.5× 224 1.3× 93 0.6× 79 0.5× 162 1.5× 35 1.2k
Elena Elefante Italy 19 644 1.5× 312 1.9× 116 0.7× 121 0.8× 80 0.7× 72 1.0k
Z. Bahloul Tunisia 16 455 1.1× 256 1.5× 60 0.4× 118 0.8× 101 0.9× 140 905
Lillian Barra Canada 18 658 1.5× 322 1.9× 171 1.1× 373 2.5× 92 0.8× 53 1.2k
Stéphan Pavy France 17 604 1.4× 220 1.3× 48 0.3× 139 0.9× 102 0.9× 32 1.0k
Roger Silvestrini Australia 13 353 0.8× 183 1.1× 100 0.6× 556 3.7× 170 1.5× 20 1.1k
Kiyoshi Takasugi Japan 18 461 1.1× 209 1.3× 100 0.6× 114 0.8× 146 1.3× 51 1.0k
Teresa Iwaniec Poland 18 350 0.8× 159 1.0× 115 0.7× 212 1.4× 146 1.3× 71 879
Jos N. Hoes Netherlands 11 527 1.2× 111 0.7× 45 0.3× 77 0.5× 95 0.9× 13 947
Chan Hong Jeon South Korea 19 361 0.8× 220 1.3× 42 0.3× 203 1.3× 194 1.7× 59 1.0k

Countries citing papers authored by Russell Buchanan

Since Specialization
Citations

This map shows the geographic impact of Russell Buchanan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Russell Buchanan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Russell Buchanan more than expected).

Fields of papers citing papers by Russell Buchanan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Russell Buchanan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Russell Buchanan. The network helps show where Russell Buchanan may publish in the future.

Co-authorship network of co-authors of Russell Buchanan

This figure shows the co-authorship network connecting the top 25 collaborators of Russell Buchanan. A scholar is included among the top collaborators of Russell Buchanan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Russell Buchanan. Russell Buchanan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gianoudis, Jenny, et al.. (2025). Changes to physical function and body composition during the first 2 years of polymyalgia rheumatica. Lara D. Veeken. 64(11). 5834–5843.
2.
Liew, David, et al.. (2025). Higher Rates of Depression in Polymyalgia Rheumatica Are Strongly Associated With Poor Physical Function. JCR Journal of Clinical Rheumatology. 31(4). 170–174.
3.
Gianoudis, Jenny, et al.. (2025). More Than Pain and Stiffness: Persistent Fatigue and Sleep Disturbance in Polymyalgia Rheumatica. The Journal of Rheumatology. 52(7). jrheum.2024–980. 1 indexed citations
4.
Liew, David, Sarah Mackie, Alice Tison, et al.. (2024). Immune Checkpoint Inhibitor-induced Polymyalgia Rheumatica. Rheumatic Disease Clinics of North America. 50(2). 255–267. 4 indexed citations
5.
Buchanan, Russell, et al.. (2024). 3D Freehand Ultrasound using Visual Inertial and Deep Inertial Odometry for Measuring Patellar Tracking. Institutional Research Information System (Università degli Studi di Trento). 1–6. 2 indexed citations
6.
Owen, Claire, Aurora Poon, Bonnia Liu, et al.. (2023). Characterising polymyalgia rheumatica on whole-body 18F-FDG PET/CT: an atlas. Rheumatology Advances in Practice. 8(1). rkae003–rkae003. 9 indexed citations
7.
Liew, David, et al.. (2023). Diagnosis of septic arthritis in the acute care setting: the value of routine intra-operative sample culture. Rheumatology Advances in Practice. 7(Supplement_1). i12–i18. 1 indexed citations
8.
McMaster, Christopher, et al.. (2022). Better diagnostic tools needed for biopsy-negative giant cell arteritis. The Lancet Rheumatology. 5(1). e8–e10. 1 indexed citations
9.
Hoi, Alberta, et al.. (2018). Assessing the quality, reliability and readability of online health information regarding systemic lupus erythematosus. Lupus. 27(12). 1911–1917. 17 indexed citations
10.
Owen, Claire, Aurora Poon, Sze Ting Lee, et al.. (2017). Fusion of positron emission tomography/computed tomography with magnetic resonance imaging reveals hamstring peritendonitis in polymyalgia rheumatica. Lara D. Veeken. 57(2). 345–353. 19 indexed citations
11.
Ng, Felix, Fabian Chiong, Russell Buchanan, & Louise M. Burrell. (2016). A rare case of Behçet disease with generalised myositis, cardiomyositis and necrotising fasciitis. BMJ Case Reports. 2016. bcr2015211983–bcr2015211983. 7 indexed citations
12.
Okada, Mali, Tien Yin Wong, Ryo Kawasaki, et al.. (2013). Retinal Venular Calibre is Increased in Patients with Autoimmune Rheumatic Disease: A Case-Control Study. Current Eye Research. 38(6). 685–690. 13 indexed citations
13.
Brand, Caroline, et al.. (2009). What factors determine patients’ preference for tumour necrosis factor inhibitors in ankylosing spondylitis?. Clinical Rheumatology. 28(5). 599–602. 5 indexed citations
14.
Chatfield, Simon, et al.. (2008). Complementary and alternative medicines in ankylosing spondylitis: a cross-sectional study. Clinical Rheumatology. 28(2). 213–217. 25 indexed citations
15.
Wines, Bruce D., Amanda L. Gavin, Maree S. Powell, et al.. (2003). Soluble FcγRIIa inhibits rheumatoid factor binding to immune complexes. Immunology. 109(2). 246–254. 30 indexed citations
16.
Drouvalakis, Katerina A., Paul J. Neeson, & Russell Buchanan. (1999). Detection of anti-phosphatidylethanolamine antibodies using flow cytometry. Cytometry. 36(1). 46–51. 11 indexed citations
17.
Briganti, Esther M., et al.. (1999). Polymorphism of the Vitamin D Receptor Gene and Corticosteroid-Related Osteoporosis. Osteoporosis International. 9(2). 134–138. 21 indexed citations
18.
Bird, Margaret, et al.. (1995). Lupus anticoagulant in the elderly may be associated with both quinine and quinidine usage. Pathology. 27(2). 136–139. 6 indexed citations
19.
Tipping, Peter G., et al.. (1988). DETECTION OF ANTI-DNA ANTIBODIES: A COMPARISON BETWEEN TWO FARR ASSAYS, CRITHIDIA LUCILIAE AND A HUMAN CHROMOSOMAL SUBSTRATE ASSAY. Lara D. Veeken. 27(3). 206–210. 2 indexed citations
20.
Cooper, Mark E., et al.. (1986). Low serum C4 concentrations and microangiopathy in type I and type II diabetes.. BMJ. 292(6523). 801–801. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026